# OnCo record nct03669965 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct03669965/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct03669965", "NCT03669965" ;
  schema:name "KRT-232 Compared to Ruxolitinib in Patients With Phlebotomy-Dependent Polycythemia Vera"@en ;
  schema:description "A phase 2 trial of KRT-232 and Ruxolitinib in myeloproliferative neoplasms, run by Kartos Therapeutics, Inc., active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct03669965/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT03669965> ;
  onco:status "active" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "2" ;
  schema:startDate "2019-01-15" ;
  onco:cancers <https://onco.cc/cancers/myeloproliferative-neoplasms/> ;
  onco:technologies <https://onco.cc/technologies/kinase-inhibitors/> ;
  onco:drugs <https://onco.cc/drugs/krt-232/>, <https://onco.cc/drugs/ruxolitinib/> ;
  onco:companies <https://onco.cc/companies/kartos-therapeutics/> .